Beijing Winsunny Pharmaceutical CO.LTD (601089) — Cash Flow-to-Debt Ratio
Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Cash Flow-to-Debt Ratio of 0.55x as of December 2024, meaning its operating cash flow of CN¥690.75 Million could theoretically repay 1% of its total liabilities (CN¥1.26 Billion) in one year. See Beijing Winsunny Pharmaceutical CO.LTD (601089) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Beijing Winsunny Pharmaceutical CO.LTD Cash Flow-to-Debt Ratio (2020–2024)
Historical debt coverage capacity for Beijing Winsunny Pharmaceutical CO.LTD across 5 annual periods. Also explore 601089 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
Year-by-year debt coverage analysis for Beijing Winsunny Pharmaceutical CO.LTD. For market capitalisation and broader financial context, see 601089 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.55x | CN¥690.75 Million | CN¥1.26 Billion | ▲ +5.6% |
| 2023 | 0.52x | CN¥555.90 Million | CN¥1.07 Billion | ▼ -10.1% |
| 2022 | 0.58x | CN¥659.76 Million | CN¥1.14 Billion | ▲ +2.5% |
| 2021 | 0.56x | CN¥528.02 Million | CN¥937.86 Million | ▲ +3.2% |
| 2020 | 0.55x | CN¥386.65 Million | CN¥709.01 Million | — |